Anticancer research
Journal
Overview
publication venue for
-
CD8-positive Tumor-infiltrating Lymphocytes and Prognosis in Radiotherapy for Uterine Cervical Squamous Cell Carcinoma..
43.
2023
-
Cervical Adenocarcinoma: A Still Under-investigated Malignancy..
43.
2023
-
Hispanic vs. Caucasian Race/Ethnicity in Adrenocortical Carcinoma Patients..
42.
2022
-
Comparative Analysis of the Antitumor Immune Profiles of Paired Radiotherapy-naive and Radiotherapy-treated Cervical Cancer Tissues..
42.
2022
-
Carbon-ion Radiotherapy for Inoperable Head and Neck Bone and Soft-tissue Sarcoma: Prospective Observational Study..
42.
2022
-
Survival After Minimally Invasive Surgery in Older Women With Endometrial Carcinoma..
42.
2022
-
Carbon-ion Radiotherapy for Oligometastatic Colorectal Cancer in the Liver or Lung..
41.
2021
-
Ovarian Cancer Treatment Stratification Using Ex Vivo Drug Sensitivity Testing..
39.
2019
-
Survival and Complication Rates of Metastasectomy in Patients With Metastatic Renal Cell Carcinoma Treated Exclusively With Targeted Therapy: A Combined Population-based Analysis..
39.
2019
-
Circulating Tumor Cells With Epithelial-to-mesenchymal Transition Phenotypes Associated With Inferior Outcomes in Primary Breast Cancer..
39.
2019
-
Radiofrequency Ablation vs. Cryoablation for Localized Hepatocellular Carcinoma: A Propensity-matched Population Study..
38.
2018
-
Particle Stability During Pressurized Intra-peritoneal Aerosol Chemotherapy (PIPAC)..
38.
2018
-
Liver-dominant Breast Cancer Metastasis: A Comparative Outcomes Study of Chemoembolization Versus Radioembolization..
38.
2018
-
ABO Blood Group and Rhesus Factor Are Not Associated with Outcomes After Radical Cystectomy for Non-metastatic Urothelial Carcinoma of the Bladder..
37.
2017
-
On-site Cytology for Development of Patient-Derived Three-dimensional Organoid Cultures - A Pilot Study..
37.
2017
-
Imaging and Pathology Correlations for Different Risk Stratification Models for Intermediate-risk Prostate Cancer..
37.
2017
-
Insurance Status and Other Non-biological Factors Predict Outcomes in Acute Myelogenous Leukemia: Analysis of Data from the National Cancer Database..
36.
2016
-
Predictors of Survival in Acute Myeloid Leukemia by Treatment Modality..
36.
2016
-
Effect of Payer Status on Relative Survival of Patients with Laryngeal Cancer..
36.
2016
-
Effect of Postmastectomy Radiation on Survival of AJCC pN2/N3 Breast Cancer Patients..
36.
2016
-
The Effect of Payer Status on Survival of Patients with Stage I/II Non-small Cell Lung Cancer: NCDB 1998-2011..
36.
2016
-
Capecitabine as a Radiosensitizer in Adjuvant Chemoradiotherapy for Pancreatic Cancer: A Retrospective Study..
35.
2015
-
Anti-tumor effect of novel cationic biomaterials in prostate cancer..
34.
2014
-
Expression of cyclin d1 and its association with disease characteristics in bladder cancer..
33.
2013
-
c-MET and HGF mRNA expression in hepatocellular carcinoma: correlation with clinicopathological features and survival..
33.
2013
-
Expression of VEGF and its receptors VEGFR1/VEGFR2 is associated with invasiveness of bladder cancer..
33.
2013
-
Radiotherapy in the management of pancreatic neuroendocrine tumors (PNET): experience at three institutions..
33.
2013
-
PTEN regulates sensitivity of melanoma cells to RO4929097, the γ-secretase inhibitor..
33.
2013
-
Dihydrotestosterone and bicalutamide do not affect periostin expression in androgen-dependent LNCaP prostate cancer cell lines..
33.
2013
-
Pelvic peritonectomy without intraperitoneal chemotherapy for localized peritoneal carcinomatosis..
33.
2013
-
A pilot study of letrozole for one year in women at enhanced risk of developing breast cancer: effects on mammographic density..
32.
2012
-
Loss of p27KIP1 expression in fully-staged node-negative breast cancer: association with lack of hormone receptors in T1a/b, but not T1c infiltrative ductal carcinoma..
31.
2011
-
Low-dose combinations of LBH589 and TRAIL can overcome TRAIL-resistance in colon cancer cell lines..
31.
2011
-
Phase II study of saracatinib (AZD0530) for patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC)..
31.
2011
-
Clinical and molecular determinants of survival in pancreatic cancer patients treated with second-line chemotherapy: results of an Italian/Swiss multicenter survey..
30.
2010
-
Molecular predictors of combination targeted therapies (cetuximab, bevacizumab) in irinotecan-refractory colorectal cancer (BOND-2 study)..
30.
2010
-
Weekly paclitaxel with intermittent imatinib mesylate (Gleevec): tolerance and activity in recurrent epithelial ovarian cancer..
30.
2010
-
Combination of PI3K/mTOR inhibition demonstrates efficacy in human chordoma..
29.
2009
-
Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1..
29.
2009
-
Concurrent radiotherapy, paclitaxel and dose escalating carboplatin in the treatment of cervical cancer--a phase I study..
28.
2008
-
High-dose chemotherapy with autologous stem cell rescue in stage IIIB inflammatory breast cancer..
28.
2008
-
The expression of TUCAN, an inhibitor of apoptosis protein, in patients with advanced non-small cell lung cancer treated with chemotherapy..
26.
2006
-
Antibody-dependent cell cytotoxicity to breast cancer targets despite inhibitory KIR signaling..
26.
2006
-
Expression of neutral amino acid transporter ASCT2 in human prostate..
23.
2003
-
Detection of the p110 beta subunit of phosphatidylinositol 3-kinase complexed with neutral endopeptidase..
22.
2002
-
Tumor volumetry as predictive and prognostic factor in the management of ovarian cancer..
22.
2002
-
Frequent LOH at hMLH1, a highly variable SNP in hMSH3, and negligible coding instability in ovarian cancer..
22.
2002
-
Validation of a polymerase chain reaction aided transcript titration assay (PATTY) for topoisomerase II in lung cancer samples..
20.
2000
-
Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer..
19.
1999
-
A PCR-aided transcript titration assay (PATTY) to measure topoisomerase I gene expression in human tumor specimens..
19.
1999
-
Radioimmunotherapy of colorectal cancer in small volume disease and in an adjuvant setting: preclinical evaluation in comparison to equitoxic chemotherapy and initial results of an ongoing phase-I/II clinical trial..
19.
1999
-
Expression of the kidney-associated differentiation glycoprotein gp160 and resistance to the antitumor effects of interferon alpha in renal cell carcinomas..
18.
1998
-
The effect of tamoxifen on established human colorectal cancer cell lines in vitro..
16.
1996
-
Expression of the retinoblastoma gene product in renal tumors..
16.
1996
-
GLUT1 expression in human breast carcinoma: correlation with known prognostic markers..
15.
1995
-
Hypoglycemia with glycerol salvage: a role in anti-neoplastic therapy?.
15.
1995
-
Recurrent deletions involving chromosomes 1, 5, 17, and 18 in colorectal carcinoma: possible role in biological and clinical behavior of tumors..
15.
1995
-
The effect of tamoxifen and fenretinimide on human colorectal cancer cell lines in vitro..
14.
1994
-
An analysis of vincristine-resistance in BHK cells pretreated with 1-beta-D-arabinofuranosylcytosine..
13.
1993
-
In vitro chemosensitivity testing of multilayered microcultures..
12.
1992
-
Phase II study of alpha-interferon plus bleomycin in advanced non-small cell lung cancer..
9.
1989
-
Production of interleukin 1 by activated blood monocytes and alveolar macrophages from melanoma patients..
8.
1988
-
Phase II trial of elliptinium in advanced renal cell carcinoma and carcinoma of the breast..
5.
1985
-
Phase I-II trial of a 5-day continuous infusion of vinblastine sulfate..
4.
1984
-
Phase II trial of 10-deazaaminopterin for advanced hypernephroma..
4.
1984
-
Monoclonal antibody localization in subcutaneous and intracranial human glioma xenografts: paired-label and imaging analysis..
4.
1984
-
Plasma levels of thyroxine and triiodothyronine in women with breast cancer..
1.
1981
-
Subnormal 24-hour mean concentration and abnormal 24-hour profile of plasma LH in the luteal phase in women with breast cancer..
1.
1981
-
Large Animal Models of Glioma: Current Status and Future Prospects.
2021
-
Polymorphisms in DNA repair gene XRCC1 and skin cancer risk: a meta-analysis.
2011
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)